Cifurtilimab
Cifurtilimab (SEA-CD40) is an agonistic nonfucosylated, human IgG1 monoclonal antibody directed against CD40. Cifurtilimab shows antitumor activities[1][2].
Product Specifications
CAS Number
1629760-27-5
Product Name Alternative
SEA-CD40
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cifurtilimab.html
Purity
95.00
Solubility
H2O
Smiles
[Cifurtilimab]
Molecular Weight
(145.1 kDa)
References & Citations
[1]Neff-LaFord H, et al. SEA-CD40 is a non-fucosylated anti-CD40 antibody with potent pharmacodynamic activity in preclinical models and patients with advanced solid tumors. Cancer Research, 2020, 80 (16_Supplement) : 5535-5535.|[2]Zeng W, et al. 438 Synergy between SEA-CD40 and chemotherapeutics drives curative antitumor activity in preclinical models. 2020.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC682187-500 1x 500 µL
HLA-DR (MHC II) (TAL 1B5), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042966-100 1x 100 µL
C1QB / Complement C1q B-Chain (C1QB/2966), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details